Merck to Invest $70M Into New Biopharma R&D Facility
Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the United States and Canada, announced a $70 million investment to expand its research and development (R&D) facility in Billerica, Mass. The new building will span 145,000 sq. ft., offering new laboratory and collaborative working space to accommodate approximately 400 new and current R&D employees focused on advancing science in oncology, immuno-oncology and immunology....
from RSSMix.com Mix ID 8246474 https://ift.tt/2T8oaNa
via Inchiriere buldozere - Tuscher & Milas Company
from RSSMix.com Mix ID 8246474 https://ift.tt/2T8oaNa
via Inchiriere buldozere - Tuscher & Milas Company
Comentarii
Trimiteți un comentariu